|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7155
|
|
pubmed:dateCreated |
1998-9-3
|
|
pubmed:abstractText |
To compare the feasibility of treatment, safety, and toxicity of intravenous amphotericin B deoxycholate prepared in either glucose or intralipid for empirical antimycotic treatment of neutropenic cancer patients.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-1379913,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-1396746,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-1425731,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-1458072,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-1490923,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-3183418,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-4197130,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-6440970,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-7219459,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-7655134,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-7729451,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-7886778,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-7986930,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-8040124,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-814803,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-8182001,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-8192439,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-826237,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-8444659,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9694753-8740098
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0959-8138
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
8
|
|
pubmed:volume |
317
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
379-84
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:9694753-Adolescent,
pubmed-meshheading:9694753-Adult,
pubmed-meshheading:9694753-Aged,
pubmed-meshheading:9694753-Amphotericin B,
pubmed-meshheading:9694753-Antifungal Agents,
pubmed-meshheading:9694753-Drug Carriers,
pubmed-meshheading:9694753-Drug Compounding,
pubmed-meshheading:9694753-Fat Emulsions, Intravenous,
pubmed-meshheading:9694753-Feasibility Studies,
pubmed-meshheading:9694753-Female,
pubmed-meshheading:9694753-Fever of Unknown Origin,
pubmed-meshheading:9694753-Glucose,
pubmed-meshheading:9694753-Humans,
pubmed-meshheading:9694753-Infusions, Intravenous,
pubmed-meshheading:9694753-Male,
pubmed-meshheading:9694753-Middle Aged,
pubmed-meshheading:9694753-Neutropenia,
pubmed-meshheading:9694753-Pneumonia,
pubmed-meshheading:9694753-Prospective Studies
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.
|
|
pubmed:affiliation |
Department of Haematology/Oncology, Hanover University Medical School, D-30625 Hanover, Germany. Patrick_Schoffski@compuserve.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Clinical Trial, Phase II
|
